Home  |   About Us  |   Courses  |   Q & A  |   Contact Us     888-844-ACES     www.aces4ce.com

Wednesday, March 14, 2012

An Aspirin Please

In 1899, German doctors and pharmacists began receiving the first of the sample packets from the drug company Bayer AG. The packets contained a fluffy white powder, called acetylsalicylic acid, which Bayer executives described as the latest modern miracle from the emerging field of organic chemistry. They asked the practitioners, in modern terms, to pilot test the compound on their patients, explaining that it had been shown in their initial human studies to relieve common pain and inflammation minus the debilitating side effects of other drugs. But, as they also explained, other uses certainly weren’t out of the picture. Bayer encouraged the practitioners to publish their results and, in a sign of 20th century things to come, to refer to the new drug by its trade name. They called it Aspirin.

More than 110 years later, researchers continue to discover new uses for aspirin. In the December 2011 issue of the journal Nature Medicine, NIDCR scientists and grantees report in mouse studies that aspirin, applied directly to the site of an experimental skull wound, helps bone marrow mesenchymal stem cells, or BMMSCs, form new bone. Aspirin does so by reducing the concentration of immune cell signaling proteins INF-γ and TNF-α in the tissue microenvironment, where the wound healing occurs. By jamming these specific wavelengths of molecular communication, the scientists found they could control certain types of T cells that inhibit the implanted BMMSCs from forming new bone. Importantly, the aspirin has no negative effects on other T cells subtypes that the researchers found are helpful to engineer new bone.

For full article: http://www.nidcr.nih.gov/Research/ResearchResults/ScienceBriefs/CurrentSNIB/February/Aspirin.htm

Website supported by www.aces4ce.com
ACES is the world's leader in providing live webcast dental continuing education


Content on this blog are for informational purposes only, is neither intended to and does not establish a standard of care, and is not a substitute for professional judgment, advice, diagnosis, or treatment. ACES is not responsible for information on external websites linked to this website.

No comments:

Post a Comment